Your browser is no longer supported. Please, upgrade your browser.
Settings
EXAS [NASD]
Exact Sciences Corporation
Index- P/E- EPS (ttm)-5.54 Insider Own0.60% Shs Outstand169.09M Perf Week3.58%
Market Cap22.07B Forward P/E- EPS next Y-2.57 Insider Trans-28.61% Shs Float167.52M Perf Month1.20%
Income-848.50M PEG- EPS next Q-1.04 Inst Own88.40% Short Float5.71% Perf Quarter-11.71%
Sales1.49B P/S14.80 EPS this Y-777.40% Inst Trans5.14% Short Ratio5.66 Perf Half Y25.64%
Book/sh18.04 P/B7.21 EPS next Y26.60% ROA-18.60% Target Price170.63 Perf Year82.08%
Cash/sh10.84 P/C11.99 EPS next 5Y- ROE-33.20% 52W Range70.75 - 159.54 Perf YTD-1.85%
Dividend- P/FCF306.11 EPS past 5Y-26.80% ROI-17.30% 52W High-20.63% Beta1.28
Dividend %- Quick Ratio3.70 Sales past 5Y106.80% Gross Margin76.20% 52W Low78.97% ATR5.35
Employees4800 Current Ratio3.80 Sales Q/Q57.70% Oper. Margin-52.00% RSI (14)46.00 Volatility2.87% 4.31%
OptionableYes Debt/Eq0.57 EPS Q/Q-601.40% Profit Margin-56.90% Rel Volume0.57 Prev Close130.04
ShortableYes LT Debt/Eq0.48 EarningsMay 04 AMC Payout- Avg Volume1.69M Price126.62
Recom1.60 SMA20-2.04% SMA50-5.21% SMA2009.90% Volume821,645 Change-2.63%
Jan-28-21Initiated Truist Buy $226
Oct-29-20Downgrade UBS Buy → Neutral $125 → $140
Oct-28-20Downgrade Citigroup Buy → Neutral $120 → $140
Oct-08-20Resumed BTIG Research Buy $140
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Apr-14-21 06:00AM  
Apr-12-21 07:26AM  
Apr-08-21 06:00AM  
Apr-06-21 03:56PM  
11:11AM  
Mar-29-21 12:07PM  
Mar-26-21 12:17PM  
Mar-23-21 12:56PM  
Mar-18-21 12:14PM  
11:30AM  
Mar-16-21 08:00AM  
Mar-09-21 10:19AM  
09:00AM  
08:37AM  
08:00AM  
Mar-08-21 06:49AM  
Mar-05-21 09:00AM  
Mar-04-21 08:30AM  
Feb-22-21 06:00AM  
Feb-21-21 06:17AM  
Feb-17-21 03:01PM  
08:00AM  
07:26AM  
06:30AM  
05:24AM  
Feb-16-21 09:22PM  
05:18PM  
04:45PM  
04:05PM  
04:05PM  
02:45PM  
Feb-15-21 10:34AM  
Feb-12-21 08:36AM  
Feb-09-21 12:30PM  
10:05AM  
Feb-01-21 06:00AM  
06:00AM  
Jan-26-21 10:19AM  
Jan-24-21 11:11PM  
Jan-14-21 12:34PM  
12:16PM  
Jan-13-21 02:45PM  
07:00AM  
06:30AM  
Jan-12-21 02:45PM  
12:48PM  
08:32AM  
Jan-11-21 11:01AM  
Jan-10-21 07:30PM  
Jan-08-21 07:00AM  
Jan-05-21 08:25AM  
06:30AM  
Dec-28-20 06:00AM  
Dec-26-20 05:17PM  
Dec-22-20 04:42PM  
05:41AM  
Dec-21-20 05:10PM  
10:08AM  
06:30AM  
Dec-18-20 07:15AM  
06:30AM  
Dec-17-20 11:45PM  
04:44PM  
10:17AM  
Dec-11-20 06:23PM  
09:00AM  
Dec-09-20 12:30PM  
09:00AM  
09:00AM  
Dec-03-20 06:30AM  
Nov-23-20 06:00AM  
Nov-14-20 12:05PM  
08:08AM  
Nov-13-20 11:11AM  
08:30AM  
Nov-08-20 09:06PM  
Nov-02-20 10:45AM  
06:00AM  
Oct-28-20 12:16PM  
10:24AM  
07:41AM  
Oct-27-20 04:35PM  
03:03PM  
02:09PM  
12:44PM  
11:26AM  
10:29AM  
10:25AM  
09:55AM  
08:19AM  
07:54AM  
07:14AM  
07:10AM  
07:01AM  
07:00AM  
Oct-26-20 09:01PM  
Oct-22-20 12:34PM  
Oct-12-20 09:00AM  
Oct-10-20 03:00PM  
Oct-09-20 06:00AM  
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEOApr 01Sale132.3022,7553,010,487776,408Apr 05 04:54 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 11Option Exercise26.0643,2411,126,92681,608Mar 15 04:37 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 11Sale130.0043,2415,621,33038,367Mar 15 04:37 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 08Option Exercise21.684,61299,98838,367Mar 10 05:22 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 05Sale121.3311,7351,423,80833,755Mar 08 05:48 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 03Sale135.022,632355,37338,361Mar 05 04:49 PM
COWARD D SCOTTChief Administrative OfficerMar 03Sale135.022,664359,6931,301Mar 05 04:48 PM
Condella SarahSVP, Human ResourcesMar 02Sale138.421,679232,40774,052Mar 03 08:27 PM
Conroy Kevin TPresident and CEOMar 02Sale138.429,7961,355,962799,163Mar 03 08:28 PM
COWARD D SCOTTChief Administrative OfficerMar 02Sale139.234,126574,4573,965Mar 03 08:30 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 02Sale139.244,230588,98940,993Mar 03 08:33 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 02Sale138.422,524349,37245,490Mar 03 08:34 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 01Option Exercise0.005,025048,014Mar 03 08:34 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Option Exercise0.005,025045,223Mar 03 08:33 PM
COWARD D SCOTTChief Administrative OfficerMar 01Option Exercise0.005,02508,091Mar 03 08:30 PM
Conroy Kevin TPresident and CEOMar 01Option Exercise0.0020,5750808,959Mar 03 08:28 PM
Condella SarahSVP, Human ResourcesMar 01Option Exercise0.003,525075,731Mar 03 08:27 PM
COWARD D SCOTTChief Administrative OfficerMar 01Option Exercise44.374,175185,2457,241Mar 02 06:56 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 01Sale137.441,603220,31642,989Mar 02 07:00 PM
Condella SarahSVP, Human ResourcesMar 01Sale137.441,098150,90972,206Mar 02 06:58 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Sale136.918,4031,150,48640,198Mar 02 06:59 PM
COWARD D SCOTTChief Administrative OfficerMar 01Sale136.965,673776,9833,066Mar 02 06:56 PM
Conroy Kevin TPresident and CEOMar 01Sale136.8831,2934,283,387788,384Mar 02 06:56 PM
WYZGA MICHAEL SDirectorFeb 26Option Exercise26.9810,108272,71421,579Mar 02 07:00 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.009,3120819,677Mar 02 06:56 PM
COWARD D SCOTTChief Administrative OfficerFeb 26Option Exercise0.003,26304,564Mar 02 06:56 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Option Exercise0.003,437048,601Mar 02 06:59 PM
Condella SarahSVP, Human ResourcesFeb 26Option Exercise0.002,357073,304Mar 02 06:58 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Option Exercise0.003,263044,592Mar 02 07:00 PM
WYZGA MICHAEL SDirectorFeb 26Sale130.1119,0212,474,8222,558Mar 02 07:00 PM
Doyle James EdwardDirectorFeb 26Sale130.112,000260,22030,459Mar 02 06:57 PM
COWARD D SCOTTChief Administrative OfficerFeb 25Sale132.966,788902,5321,301Mar 01 06:10 PM
COWARD D SCOTTChief Administrative OfficerFeb 24Sale136.306,062826,2518,089Feb 25 07:23 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 24Sale136.305,842796,26541,329Feb 25 07:24 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Sale136.304,449606,39945,164Feb 25 07:24 PM
Conroy Kevin TPresident and CEOFeb 24Sale136.3016,4202,238,046810,365Feb 25 07:22 PM
Condella SarahSVP, Human ResourcesFeb 24Sale136.302,057280,36970,947Feb 25 07:21 PM
Condella SarahSVP, Human ResourcesFeb 23Option Exercise0.004,300073,004Feb 25 07:21 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0034,3250826,785Feb 25 07:22 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.009,300049,613Feb 25 07:24 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Option Exercise12.8631,600406,50032,901Feb 25 07:23 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 23Option Exercise0.0011,575047,171Feb 25 07:24 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Sale136.5118,7502,559,56214,151Feb 25 07:23 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 19Sale143.381,696243,1725,445Feb 22 06:01 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise0.003,64907,141Feb 22 06:01 PM
COWARD D SCOTTChief Administrative OfficerFeb 18Sale140.791,980278,7641,301Feb 22 06:00 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 17Sale142.662,020288,17340,313Feb 18 07:30 PM
Conroy Kevin TPresident and CEOFeb 17Sale142.6615,8252,257,594792,460Feb 18 07:27 PM
COWARD D SCOTTChief Administrative OfficerFeb 17Sale142.661,992284,1793,281Feb 18 07:28 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 17Sale142.661,033147,3683,492Feb 18 07:33 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 17Sale142.662,131304,00835,596Feb 18 07:31 PM
Condella SarahSVP, Human ResourcesFeb 17Sale142.661,033147,36868,704Feb 18 07:25 PM
Condella SarahSVP, Human ResourcesFeb 16Option Exercise0.002,030069,737Feb 18 07:25 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 16Option Exercise0.003,972037,727Feb 18 07:31 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 16Option Exercise0.002,03004,525Feb 18 07:33 PM
COWARD D SCOTTChief Administrative OfficerFeb 16Option Exercise0.003,97205,273Feb 18 07:28 PM
Conroy Kevin TPresident and CEOFeb 16Option Exercise0.0031,1320808,285Feb 18 07:27 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 16Option Exercise0.003,972042,333Feb 18 07:30 PM
Conroy Kevin TPresident and CEOFeb 05Option Exercise5.7017,54399,995777,153Feb 09 04:34 PM
Conroy Kevin TPresident and CEOFeb 01Sale138.0730,3444,189,596759,610Feb 03 04:20 PM
Conroy Kevin TPresident and CEOJan 04Sale128.7431,8144,095,734825,704Jan 07 09:05 AM
Zanotti Katherine SDirectorDec 14Sale132.0620,0002,641,18221,907Dec 14 06:15 PM
Conroy Kevin TPresident and CEODec 01Sale124.5630,5773,808,660857,518Dec 02 06:28 PM
Conroy Kevin TPresident and CEONov 02Sale121.1132,8193,974,738888,095Nov 03 04:49 PM
Conroy Kevin TPresident and CEOOct 01Sale103.5527,4252,839,829920,914Oct 02 05:54 PM
Hoof TorstenGeneral Manager, InternationalSep 24Option Exercise41.534,401182,7746,418Sep 28 04:33 PM
Hoof TorstenGeneral Manager, InternationalSep 24Sale80.004,401352,0802,017Sep 28 04:33 PM
Conroy Kevin TPresident and CEOSep 01Sale75.0319,9271,495,123948,339Sep 02 04:32 PM
Hoof TorstenGeneral Manager, InternationalAug 19Option Exercise43.401,51665,7949,981Aug 21 04:31 PM
Hoof TorstenGeneral Manager, InternationalAug 19Sale84.907,964676,1442,017Aug 21 04:31 PM
Hoof TorstenGeneral Manager, InternationalAug 17Option Exercise0.002,55108,465Aug 19 04:15 PM
Conroy Kevin TPresident and CEOAug 03Sale93.8025,1982,363,560968,266Aug 04 05:18 PM
Zanotti Katherine SDirectorJul 31Option Exercise8.5221,029179,16762,936Aug 04 04:54 PM
LEVANGIE DANIEL JDirectorJul 31Option Exercise9.309,86591,69924,881Aug 04 04:58 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Option Exercise21.686,638143,91275,861Aug 04 05:02 PM
Carey Thomas D.DirectorJul 31Option Exercise9.2415,620144,32952,492Aug 04 05:21 PM
Carey Thomas D.DirectorJul 31Sale94.0030,6202,878,28021,872Aug 04 05:21 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Sale93.8337,5003,518,77138,361Aug 04 05:02 PM
LEVANGIE DANIEL JDirectorJul 31Sale94.009,865927,31015,016Aug 04 04:58 PM
Zanotti Katherine SDirectorJul 31Sale94.0021,0291,976,72641,907Aug 04 04:54 PM
Doyle James EdwardDirectorJul 31Sale94.002,539238,66632,459Aug 04 04:45 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Sale95.588,746835,94369,223Jul 30 08:18 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 28Option Exercise94.8118,7501,777,68877,969Jul 30 08:18 PM
Zanotti Katherine SDirectorJul 28Sale96.131,164111,89541,907Jul 30 06:49 PM